SFX by Ex Libris Inc.

Title:	Comparison of the Effects of Thioridazine and Mesoridazine on the QT Interval in Healthy Adults After Single Oral Doses
Source:	Clinical Pharmacology & Therapeutics [0009-9236] Salih, I S M yr:2007

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hancox, Jules C C. "hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656." Biochemical and biophysical research communications 351.1 (2006): 273-80.
description	2.	Riedel, M. "Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms." European archives of psychiatry and clinical neuroscience 257.6 (2007): 360-370.
description	3.	Richtand, Neil M. "Dopamine and Serotonin Receptor Binding and Antipsychotic Efficacy." Neuropsychopharmacology 32.8 (2006): 1715-1726.
description	4.	Shah, Rashmi R R. "Cardiac repolarisation and drug regulation: Assessing cardiac safety 10 years after the CPMP guidance." Drug safety 30.12 (2007): 1093-1110.
description	5.	Salvi, S. "Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development." British Journal of Pharmacology 159.1 (2009): 34-48.
description	6.	Taylor D, P. "Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia." Evidence-based mental health 10.3 (2007): 76-76.
description	7.	Nakamura, K. "Anti-KCNH2 antibody-induced long QT syndrome: novel acquired form of long QT syndrome." Journal of the American College of Cardiology 50.18 (2007): 1808-1809.
description	8.	Naito, S. "Current opinion: safety evaluation of drug metabolites in development of pharmaceuticals." Journal of toxicological sciences 32.4 (2007): 329-41.
description	9.	Thanacoody, R. "Factors affecting drug concentrations and QT interval during thioridazine therapy." Clinical pharmacology and therapeutics 82.5 (2007): 555-65.
description	10.	Kapur, S. "Half a century of antipsychotics and still a central role for dopamine D-sub-2 receptors." Progress in neuro-psychopharmacology & biological psychiatry 27.7 (2003): 1081-90.
description	11.	Swartz, Marvin S S. "Effectiveness of atypical antipsychotics for substance use in schizophrenia patients." Schizophrenia Research 94.1 (2007): 114-8.
description	12.	Pacher, P. "Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?" Current pharmaceutical design 10.20 (2004): 2463-75.
description	13.	McGrath, John J. "Thought experiments on the incidence and prevalence of schizophrenia 'under the influence' of cannabis." Addiction 102.4 (2007): 514-515.
description	14.	Sulser, T. "Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy." Allergy 62.11 (2007): 1270-6.
description	15.	Grace, A A A. "Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia." Neuroscience 41.1 (1991): 1-24.
description	16.	Reulbach, U. "Managing an effective treatment for neuroleptic malignant syndrome." Critical care 11.1 (2007).
description	17.	Carmichael, Suzan L L. "Maternal corticosteroid use and orofacial clefts." American journal of obstetrics and gynecology 197.6 (2007): 585-585.
description	18.	Mehta, V. "Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial." Journal of child neurology 22.10 (2007): 1191-7.
description	19.	ssler, W. "Family Burden During Exacerbation of Schizophrenia: Quantification and Determinants of Additional Costs." The International journal of social psychiatry 51.3 (2005): 259-264.
description	20.	Goldberg, Joseph F. "Effectiveness of quetiapine in rapid cycling bipolar disorder: A preliminary study." Journal of Affective Disorders 105.1 (2007): 305-310.